A novel gene signature to predict immune infiltration and outcome in patients with prostate cancer.

Oncoimmunology · 2020 · PMC7458664 · PMID 32923125

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = .08so close (0.05 < p ≤ 0.1)

However, this trend did not reach statistical significance ( P = .08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.